NEW YORK, April 19 (Reuters) - Amgen Inc.'s. anemia drug Aranesp showed no increased risk of death compared to a placebo in a study of small-cell lung cancer patients undergoing chemotherapy, sending ...
Darbepoetin alfa (DA) 200 mcg every 2 weeks (Q2W) vs epoetin alfa (Epo) 40,000 U weekly (QW) in anemic patients (pts) receiving chemotherapy (ctx) ...
Prechemotherapy hemoglobin (Hgb) and cognitive impairment among breast cancer patients This is an ASCO Meeting Abstract from the 2005 ASCO Annual Meeting. This abstract does not include a full text ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results